@FierceMedDev: ICYMI: Magic material: graphene protects chemotherapy, but silver-lined catheters break it down. Article | Follow @FierceMedDev
@StacyALawrence: Aum Cardio raises $5M to back hand-held, in-office CAD Dx device. Article | Follow @StacyALawrence
@EmilyWFierce: The experience of having your blood drawn by Theranos, as laid out by @danmunro. More | Follow @EmilyWFierce
> Becton Dickinson ($BDX) has saved more than $25 million in its efforts to become more energy efficient over the last 5 years. It's laid out its sustainability goals through 2020 in a new report. More
> Endo's ($ENDP) American Medical Systems has settled more than 100 lawsuits related to its vaginal mesh devices Apogee and Perigee. More
> Mitek Sports Medicine, part of Johnson & Johnson ($JNJ) company DePuy Synthes, is launching two new hand-held, energy-based radiofrequency orthopedic devices: the VAPR TRIPOLAR 90 Suction Electrode and the VAPR ARCTIC Suction Electrode. More
> Grove Instruments, which had hoped to develop a device to measure blood sugar without needles, has filed for bankruptcy instead. Here's the story of its downfall. Article
Biotech News
@FierceBiotech: Roche hustles to FDA with PhII PD-L1 cancer success for 'breakthrough' star atezolizumab. News | Follow @FierceBiotech
@JohnCFierce: You want to see why execs are leaving Big Pharma for biotech? It's where the money is. Report | Follow @JohnCFierce
@DamianFierce: Actual line: "Sorrento recently entered into a definitive agreement with NantPharma to acquire the rights for Cynviloq™ from Sorrento." | Follow @DamianFierce
> As schizophrenia rivals rush in, Otsuka and Lundbeck gain FDA OK for Rexulti. News
> Anacor soars as its eczema cream succeeds in Phase III. Article
Pharma News
@FiercePharma: Did squirrels pass a killer virus to people? FierceAnimalHealth story | Follow @FiercePharma
@EricPFierce: Which companies had highest comped CEOs? Hint, most are U.S. and did not necessarily make the most money. Special report | Follow @EricPFierce
@CarlyHFierce: I triple-dog-dare someone to make this new creepy-as-hell $GSK vaccine ad their Twitter pic. Photo | Follow @CarlyHFierce
> Otsuka, Lundbeck bag blockbuster FDA approval for long-acting antipsychotic Rexulti. More
> European safety watchdog digs into HPV vaccines again. Article
Animal Health News
> FDA cracks down on Vegas firm selling unapproved kidney drug for dogs and cats. Article
> Perdue ditches all antibiotics for new chicken line, General Mills goes cage-free. Report
> Did squirrels pass a killer virus to people? More
> Senate committee, USDA, poultry producers meet to discuss deadly U.S. avian flu outbreak. Story
> Sweden's Oasmia regains rights to cancer drugs from Zoetis, files for $23M IPO. Article
Biotech IT News
> 21st Century Cures Act clears House with data sharing, standardization sections intact. Story
> Genomics vs YouTube: Which will have the greater computing requirements in 2025? More
> GSK working to build Apple's ResearchKit into its clinical trials. Report
> Financially motivated hackers break into 3 major pharma companies in 18 months. Article
> Core Informatics snags $17.5M to fuel lab software land grab. Story
Pharma Marketing News
> Novartis off to scorching start with Copaxone generic Glatopa. Article
> Novo Nordisk looks past blockbuster Victoza with PhIII success for weekly GLP-1 med. Item
> For Entresto rollout, Novartis marketing mixes tried-and-true with new-and-different. Story
> How does the Keytruda-Opdivo marketing battle stack up? More
> GSK's big, bad whooping cough vaccination campaign bares its teeth. Article